Orbimed Advisors LLC’s Eli Lilly & Co Position
Does Orbimed Advisors LLC own Eli Lilly & Co (LLY)? Yes — 236.8K shares worth $218M (+4.32% of its 13F portfolio) as of Q1 2026, down from 301.2K shares the prior filed quarter.
Position Value
$218M
Q1 2026
Shares
236.8K
% of Portfolio
+4.32%
Quarters Held
13
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 236.8K | $218M | +4.32% |
| Q4 2025 | 301.2K | $324M | +6.61% |
| Q3 2025 | 301.2K | $230M | +5.40% |
| Q2 2025 | 337.6K | $263M | +6.57% |
| Q1 2025 | 337.6K | $279M | +6.65% |
| Q4 2024 | 337.6K | $261M | +5.36% |
| Q3 2024 | 337.6K | $299M | +5.43% |
| Q2 2024 | 337.6K | $306M | +6.04% |
| Q1 2024 | 360.8K | $281M | +5.14% |
| Q4 2023 | 365.4K | $213M | +4.25% |
| Q3 2023 | 186.0K | $100M | +2.12% |
| Q2 2023 | 186.0K | $87M | +1.58% |
| Q1 2023 | 186.0K | $64M | +1.25% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of LLY.